Abstract: A precursor comprises a tungsten precursor and a carbon-containing material. The precursor comprises less than 0.02% by weight of the carbon-containing material based on a total weight of the precursor. A method for purifying a tungsten precursor may comprise at least one of the following steps: obtaining a source vessel containing a tungsten precursor and a carbon-containing material; separating the tungsten precursor from at least a first portion of the carbon-containing material; recovering a precursor in a collection vessel; or any combination thereof.

Abstract: The present invention features solid pharmaceutical compositions comprising Compound 1 and Compound 2. In one embodiment, the solid pharmaceutical composition includes (1) a first layer which comprises 100 mg Compound 1, as well as a pharmaceutically acceptable hydrophilic polymer and a pharmaceutically acceptable surfactant, all of which are formulated in amorphous solid dispersion; and (2) a second layer which comprises 40 mg Compound 2, as well as a pharmaceutically acceptable hydrophilic polymer and a pharmaceutically acceptable surfactant, all of which are formulated in amorphous solid dispersion.

Abstract: Methods and systems for producing carbon-negative hydrogen and renewable natural gas from biomass are included herein. In an embodiment, the method may include gasifying biomass in a gasification unit to form a first stream comprising syngas. The syngas may include methane, hydrogen, carbon dioxide, carbon monoxide, ethylene, and water. The method may also include reacting the carbon monoxide with water in the presence of a catalyst to form a second stream. The second stream may include a greater hydrogen concentration than the first stream. The method may further include separating at least a portion of the second stream to form a hydrogen stream and a natural gas stream. The hydrogen stream may have a greater concentration of hydrogen than the second stream. The natural gas stream may have a greater concentration of methane than the second stream.

Abstract: An electrical device can include a sensor module that measures at least one parameter, where the at least one parameter is associated with determining the presence of a living being in a volume of space. The electrical device can also include a controller coupled to the sensor module, where the controller receives a measurement of the at least one parameter to determine whether the living being is in the volume of space. The electrical device can further include at least one ultraviolet (UV) light source coupled to the controller, which operates the at least one UV light source to emit UV light when the living being is not in the volume of space, and where the controller prevents the at least one UV light source from emitting the UV light when the living being is in the volume of space.

Abstract: A reactive hot melt (RHM) composition is provided as a mixture of a urethane prepolymer which is a reaction product of at least one crystallizable polyol, a perfluoropolyether polyol, and at least one isocyanate, a filler material, and a teachable plasticizer consisting of an aliphatic ester of a carboxylic acid.

Abstract: A reactive hot melt (RHM) composition is provided as a mixture of a urethane prepolymer which is a reaction product of at least one crystallizable polyol, a perfluropolyether polyol, and at least one isocyanate, a filler material, and a teachable plasticizer consisting of an aliphatic ester of a carboxylic acid.

Abstract: Wood laminates may comprise a plurality of wood substrates and an adhesive disposed between at least a portion of at least two of the wood substrates, the adhesive comprising a substituted cellulose ester that comprises a cellulose polymer backbone having an organic ester substituent and an inorganic ester substituent that comprises an inorganic, nonmetal atom selected from the group consisting of sulfur, phosphorus, boron, and chlorine. In some instances the adhesive may be substantially formaldehyde-free.

Abstract: Engineered wood may be produced with substituted cellulose ester adhesives. For example, an engineered wood may comprise a plurality of wood substrates that independently comprise a lignin-containing material (e.g., wood dust, wood particles, wood chips, and the like), the plurality of wood substrates being adhered together with an adhesive that comprises a substituted cellulose ester that comprises a cellulose polymer backbone having an organic ester substituent and an inorganic ester substituent that comprises an inorganic, nonmetal atom selected from the group consisting of sulfur, phosphorus, boron, and chlorine.

Abstract: A substituted cellulose ester having a cellulose backbone with an organic ester substituent and an inorganic ester substituent derived from the inorganic ester oxoacid catalyst may be utilized in adhesive compositions and articles produced therewith. Producing a substituted cellulose ester may, in some embodiments, involve providing a cellulose ester mixture that comprises a cellulose ester and a solvent; and hydrolyzing a mixture that comprises the cellulose ester mixture, water, and an inorganic ester oxoacid catalyst so as to yield a substituted cellulose ester having a cellulose backbone with an organic ester substituent and an inorganic ester substituent derived from the inorganic ester oxoacid catalyst.

Abstract: Wood laminates may comprise a plurality of wood substrates and an adhesive disposed between at least a portion of at least two of the wood substrates, the adhesive comprising a substituted cellulose ester that comprises a cellulose polymer backbone having an organic ester substituent and an inorganic ester substituent that comprises an inorganic, nonmetal atom selected from the group consisting of sulfur, phosphorus, boron, and chlorine. In some instances the adhesive may be substantially formaldehyde-free.

Abstract: Fibrous substrates may be adhered to other substrates utilizing substituted cellulose ester adhesives that comprises a cellulose polymer backbone having an organic ester substituent and an inorganic ester substituent that comprises an inorganic, nonmetal atom selected from the group consisting of sulfur, phosphorus, boron, and chlorine.

Abstract: The present disclosure provides a multi-ply tissue product, also referred to herein as a tissue laminate, wherein the plies are adhesively adjoined by the zoned application of an adhesive. The zoned application of adhesive results in plies being adhesively joined by two or more longitudinally oriented strips of adhesive adjacent to the lateral edges of the ply. The resulting adhesively joined tissue has relatively high degrees of ply attachment, yet has relatively low stiffness.

Abstract: Engineered wood may be produced with substituted cellulose ester adhesives. For example, an engineered wood may comprise a plurality of wood substrates that independently comprise a lignin-containing material (e.g., wood dust, wood particles, wood chips, and the like), the plurality of wood substrates being adhered together with an adhesive that comprises a substituted cellulose ester that comprises a cellulose polymer backbone having an organic ester substituent and an inorganic ester substituent that comprises an inorganic, nonmetal atom selected from the group consisting of sulfur, phosphorus, boron, and chlorine.

Abstract: This invention relates to the structure of members of the epidermal growth factor (EGF) receptor family and to receptor/ligand interactions. In particular, it relates to the field of using the EGF receptor family structure to select and screen for compounds that inhibit the formation of active receptor dimers.

Abstract: More particularly, the present invention relates to the crystal structure of the ErbB2, in particular the crystal structure of an extracellular portion of ErbB2 and to methods of using the crystal and related structural information to screen for and design compounds that interact with ErbB2, or variants of thereof.

Abstract: The present invention relates to truncated EGF receptor molecules that exhibit increased binding affinities for EGFR ligands such as EGF and TGF1. The present invention also relates to methods of screening for EGF receptor ligands and methods of treatment which involve the use of these molecules.

Abstract: A freestanding automotive tire and wheel cover comprises a shell that is open against the ground and inside the wheel well adjacent to an interior sidewall of a tire. The bottom edge of the shell rests on the ground. The shell protects the outer sidewall and tread from ultraviolet radiation, weather and other damaging elements. The shell may include corner braces or a flared section for extra rigidity and support, or a separate base member may be attached to the shell for the same purpose. A retention strap is secured to the shell by buckles or snaps. An inner wheel shroud provides extra security is attaching to the tire and wheel and protects most of the interior side of the tire and wheel. The shells may be tapered to permit multiple shells to nest together and a planar sidewall cover permits attachment of a decal.

Abstract: The present invention relates to an improved process for the production of carbodiimide modified organic isocyanate, preferably a polymethylene polyphenylisocyanate, and most preferably diphenylmethane diisocyanate. This process includes (1) neutralizing acidic impurities in an organic isocyanate, (2) partially carbodiimidizing isocyanate groups of the neutralized organic isocyanate, and (3) terminating the carbodiimidization reaction.

Abstract: This invention relates to a method of inhibiting FC receptor binding of immunoglobulin comprising the use of a Fc receptor modulating compound which binds to defined surfaces on a Fc receptor. The present invention also relates to a method for treating a variety of diseases using a Fc receptor modulating compound.

Abstract: A polyurethane adhesive composition having a long pot life that does not cause its user to experience breathing difficulty is described. In one embodiment, the adhesive is prepared from a mixture of a high molecular weight component, an isocyanate, and a proton donor.